These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 12387512)
1. Metformin adjunctive therapy with insulin improves glycemic control in patients with type 1 diabetes mellitus: a pilot study. Gómez R; Mokhashi MH; Rao J; Vargas A; Compton T; McCarter R; Chalew SA J Pediatr Endocrinol Metab; 2002; 15(8):1147-51. PubMed ID: 12387512 [TBL] [Abstract][Full Text] [Related]
2. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison. Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076 [TBL] [Abstract][Full Text] [Related]
3. Metformin as additional therapy in adolescents with poorly controlled type 1 diabetes: randomised placebo-controlled trial with aspects on insulin sensitivity. Särnblad S; Kroon M; Aman J Eur J Endocrinol; 2003 Oct; 149(4):323-9. PubMed ID: 14514347 [TBL] [Abstract][Full Text] [Related]
4. Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy. Malone JK; Kerr LF; Campaigne BN; Sachson RA; Holcombe JH; Clin Ther; 2004 Dec; 26(12):2034-44. PubMed ID: 15823767 [TBL] [Abstract][Full Text] [Related]
5. Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial. Derosa G; Cicero AF; Gaddi AV; Ciccarelli L; Piccinni MN; Salvadeo S; Pricolo F; Fogari E; Ghelfi M; Ferrari I; Fogari R Clin Ther; 2005 Sep; 27(9):1383-91. PubMed ID: 16291411 [TBL] [Abstract][Full Text] [Related]
6. Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes: A Randomized Clinical Trial. Libman IM; Miller KM; DiMeglio LA; Bethin KE; Katz ML; Shah A; Simmons JH; Haller MJ; Raman S; Tamborlane WV; Coffey JK; Saenz AM; Beck RW; Nadeau KJ; JAMA; 2015 Dec; 314(21):2241-50. PubMed ID: 26624824 [TBL] [Abstract][Full Text] [Related]
7. Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia. Ushakova O; Sokolovskaya V; Morozova A; Valeeva F; Zanozina O; Sazonova O; Zhadanova E; Starceva M; Kazakova E; Saifullina M; Shapiro I; Tarasov A; Al-Tayar B; Starkova N Clin Ther; 2007 Nov; 29(11):2374-84. PubMed ID: 18158078 [TBL] [Abstract][Full Text] [Related]
8. Usefulness of the addition of metformin to insulin in pediatric patients with type 1 diabetes mellitus. Urakami T; Morimoto S; Owada M; Harada K Pediatr Int; 2005 Aug; 47(4):430-3. PubMed ID: 16091082 [TBL] [Abstract][Full Text] [Related]
9. Effects of Metformin Added to Insulin in Adolescents with Type 1 Diabetes: An Exploratory Crossover Randomized Trial. Yang D; Yan J; Deng H; Yang X; Luo S; Zheng X; Lv J; Liang W; Hong M; Wu Z; Yao B; Weng J; Xu W J Diabetes Res; 2020; 2020():7419345. PubMed ID: 33457425 [TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone/metformin fixed-dose combination compared with uptitrated metformin alone in type 2 diabetes mellitus: a 24-week, multicenter, randomized, double-blind, parallel-group study. Bailey CJ; Bagdonas A; Rubes J; McMorn SO; Donaldson J; Biswas N; Stewart MW Clin Ther; 2005 Oct; 27(10):1548-61. PubMed ID: 16330291 [TBL] [Abstract][Full Text] [Related]
11. Benefits of metformin add-on insulin therapy (MAIT) for HbA1c and lipid profile in adolescents with type 1 diabetes mellitus: preliminary report from a double-blinded, placebo-controlled, randomized clinical trial. Sheikhy A; Eydian Z; Fallahzadeh A; Shakiba M; Hajipour M; Alaei M; Mosallanejad A; Saneifard H J Pediatr Endocrinol Metab; 2022 Apr; 35(4):505-510. PubMed ID: 35249270 [TBL] [Abstract][Full Text] [Related]
12. A Randomized, Double-Blind, Placebo-Controlled Trial of Adjunctive Metformin Therapy in Overweight/Obese Youth with Type 1 Diabetes. Nwosu BU; Maranda L; Cullen K; Greenman L; Fleshman J; McShea N; Barton BA; Lee MM PLoS One; 2015; 10(9):e0137525. PubMed ID: 26367281 [TBL] [Abstract][Full Text] [Related]
13. Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial. Barnett AH; Burger J; Johns D; Brodows R; Kendall DM; Roberts A; Trautmann ME Clin Ther; 2007 Nov; 29(11):2333-48. PubMed ID: 18158075 [TBL] [Abstract][Full Text] [Related]
14. Improved glycemic control with insulin glargine versus pioglitazone as add-on therapy to sulfonylurea or metformin in patients with uncontrolled type 2 diabetes mellitus. Meneghini LF; Traylor L; Schwartz SL Endocr Pract; 2010; 16(4):588-99. PubMed ID: 20350924 [TBL] [Abstract][Full Text] [Related]
15. Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis. Karagiannis T; Paschos P; Paletas K; Matthews DR; Tsapas A BMJ; 2012 Mar; 344():e1369. PubMed ID: 22411919 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes: a 54-week study. Williams-Herman D; Johnson J; Teng R; Luo E; Davies MJ; Kaufman KD; Goldstein BJ; Amatruda JM Curr Med Res Opin; 2009 Mar; 25(3):569-83. PubMed ID: 19232032 [TBL] [Abstract][Full Text] [Related]
17. Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized study. Lund SS; Tarnow L; Astrup AS; Hovind P; Jacobsen PK; Alibegovic AC; Parving I; Pietraszek L; Frandsen M; Rossing P; Parving HH; Vaag AA PLoS One; 2008; 3(10):e3363. PubMed ID: 18852875 [TBL] [Abstract][Full Text] [Related]
18. An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with metformin as adjunctive therapy in patients with type 2 diabetes poorly controlled on a sulfonylurea. Barnett AH; Dreyer M; Lange P; Serdarevic-Pehar M Diabetes Care; 2006 Jun; 29(6):1282-7. PubMed ID: 16732009 [TBL] [Abstract][Full Text] [Related]
19. Effects of initiating insulin and metformin on glycemic control and inflammatory biomarkers among patients with type 2 diabetes: the LANCET randomized trial. Pradhan AD; Everett BM; Cook NR; Rifai N; Ridker PM JAMA; 2009 Sep; 302(11):1186-94. PubMed ID: 19755697 [TBL] [Abstract][Full Text] [Related]
20. Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study. Roberts VL; Stewart J; Issa M; Lake B; Melis R Clin Ther; 2005 Oct; 27(10):1535-47. PubMed ID: 16330290 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]